A potent GSK-3beta inhibitor (IC50=22 nM)1. Also inhibits CDK1 (IC50=180 nM) and CDK5 (IC50=100 nM)1. Displays antimitotic properties and induces endoreplication following prophase arrest in HBL-100 cells2. Possesses antiangiogenic activity3. Attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimers disease4. Cell permeable.
* VAT and and shipping costs not included. Errors and price changes excepted